UroGen Pharma (URGN) Stock Price & Financial Analysis
UroGen Pharma Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About UroGen Pharma
What is the current stock price for URGN?
As of the latest trading session, URGN stock trades at $31.95. The 52-week range is $12.73–$32.37, with a day range of $30.14–$32.04.
What is the P/E ratio for URGN?
The P/E ratio (Price-to-Earnings) for URGN is shown in the Key Statistics section. This valuation metric helps compare UroGen Pharma Ltd. to industry peers.
Does URGN pay dividends?
UroGen Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for URGN?
Based on 1 analyst, the consensus for URGN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of URGN?
UroGen Pharma's market capitalization is $1.54B, classifying it as a small-cap company. UroGen Pharma operates in the Healthcare sector within the Biotechnology industry.